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Examining the Evidence: Progesterone Supplementation During Fresh
and Frozen Embryo Transfer
Post Test Evaluation – Course #G5483-14-R
To obtain 1.5 hours of AMA PRA Category I credit™, physicians must receive a score of 75% or better on the
test taken. All posttests must be completed and submitted to: Penn State College of Medicine, Continuing
Education (G220), 44 E Granada Ave., Rm 1108, PO Box 851, Hershey, PA 17033 or fax to 717-531-5604 or
sent via email to ContinuingEd@hmc.psu.edu.
1. Which of the following statements establishes the evidence of the need for progesterone
supplementation in ART cycles?
a. The cyclic secretion of estrogen and progesterone leads to morphological and physiological changes in
the endometrium that create a suitable environment for embryo implantation and maintenance of early
pregnancy.
b. Administration of progesterone receptor antagonists within the ﬁrst 7 weeks of pregnancy induces
abortion.
c. The potential for implantation is lessened if there is a decrease in the amount or duration of
progesterone production by the corpus luteum or if there is poor endometrial response to progesterone.
d. All of the above
2. Which of the following statements concerning progesterone supplementation in embryo transfer cycles
is NOT TRUE?
a. Progesterone supplementation signiﬁcantly increases pregnancy rates in IVF.
b. Progesterone administration for luteal phase support signiﬁcantly increases the live birth rate.
c. The live birth rate is signiﬁcantly higher in women who receive vaginal progesterone starting on the day
of frozen embryo transfer versus not using progesterone supplementation
d. Oral administration of progesterone is associated with superior outcomes compared with intramuscular
and vaginal administration.
3. The timing of progesterone supplementation in stimulated IVF cycles should not be too early or too late.
The optimal timing appears to be:
a. Up to 24 hours after oocyte retrieval
b. 24 to 72 hours after oocyte retrieval
c. 72 to 96 hours after oocyte retrieval
d. More than 96 hours after oocyte retrieval
4. Which of the following is NOT TRUE concerning progesterone administration?
a. There are no differences between vaginal and IM progesterone administration groups with respect to
positive β-hCG and ongoing pregnancy rates
b. Serum progesterone levels correlate with endometrial histology and pregnancy outcome.
c. Measuring progesterone serum levels only conﬁrms that the patient is taking progesterone or that
ovulation has taken place in the natural cycle.
d. Vaginal (micronized or 8% gel formulations) progesterone administration consistently yields higher
endometrial progesterone concentrations than does intramuscular administration.
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5. The ﬁrst uterine pass effect is:
a. The delay in the initiation of progesterone administration
b. The difference in the timing of vaginal compared with intramuscular progesterone supplementation
c. The preferential uptake of progesterone by the endometrium after vaginal administration
d. The time equivalent to the day of or the day after oocyte retrieval
6. Patient satisfaction with treatment is an important consideration in progesterone supplementation.
The primary deterrent to patient satisfaction is:
a. Risk of cellulitis with intramuscular injections and the continuing need for injections
b. Difﬁculty of use
c. Time to administer the drug
d. Interference with coitus
7. Published data demonstrate all of the following EXCEPT:
a. Higher patient satisfaction and tolerability with daily administration of a vaginal gel formulation than
for either intramuscular or vaginal tablet and capsule formulations.
b. Tolerability with both vaginal gel and insert formulations is similar, convenience of administration may
be a factor for some patients as the inserts require administration two or three times daily compared
with once daily for the gel formulation.
c. Although luteal phase bleeding may be more common following vaginal gel administration when
compared to IM progesterone, it does not affect pregnancy outcome and may be mitigated with
concomitant estrogen use.
d. If overall satisfaction with treatment is low, it does not translate to extra patient and clinic burdens.
8. Based on the literature, which of the following statements regarding progesterone supplementation is
NOT TRUE:
a. Progesterone administration is important for successful implantation.
b. Properly timed and appropriate dosage regimens of vaginal progesterone supplementation during
stimulated IVF-ET cycles achieve birth rates at least equivalent to intramuscular progesterone
supplementation.
c. Serum progesterone levels do reﬂect the actual absorption of progesterone or levels of progesterone in
endometrial tissue and/or the level of endometrial support.
d. Selection of a vaginal progesterone formulation can signiﬁcantly affect patient satisfaction.
